New trends and future directions of research in hand and composite tissue allotransplantation

Journal of the American Society for Surgery of the Hand

Volumn 3, Issue 3, 2003, Pages 170-174

  Petit, François ^a,b,c   Minns, Alicia B ^a,b,c   Hettiaratchy, Shehan P ^a,b,c   Mathes, David W ^a,b,c   Randolph, Mark A ^a,b,c   Lee, W P Andrew ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN A; DIPHTHERIA TOXIN; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; IMMUNOTOXIN; LEFLUNOMIDE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RAPAMYCIN; STEROID; TACROLIMUS;

ALLOTRANSPLANTATION; ARTICLE; BONE MARROW CELL; CHIMERA; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; COMPOSITE GRAFT; DONOR; DRUG ACTIVITY; DRUG PENETRATION; DRUG TARGETING; FUTUROLOGY; GRAFT SURVIVAL; HAND SURGERY; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; NONHUMAN; PLASTIC SURGERY; RECIPIENT; SIDE EFFECT; SURVIVAL TIME;

EID: 0041912380     PISSN: 15310914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1531-0914(03)00070-6     Document Type: Article

References (38)

1. Dubernard JM, Owen ER, Lanzetta M, Hakim N. What is happening with hand transplants. Lancet 2001;357:1711-1712.
2. Petit F, Minns AB, Dubernard JM, Hettiaratchy S, Lee WP. Composite tissue allotransplantation and reconstructive surgery: first clinical applications. Ann Surg 2003;237:19-25.
3. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991;87:401-411.
4. Mathes DW, Randolph MA, Lee WP. Strategies for tolerance induction to composite tissue allografts. Microsurgery 2000; 20:448-452.
5. Auchincloss HJ, Sykes M, Sachs DH. Transplantation immunology. In: Paul WE, ed: Fundamental Immunology. Philadelphia, Lippincott-Raven, 1999, 1175-1235
6. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984;307:168-170.
7. Leong LY, Qin S, Cobbold SP, Waldmann H. Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression. Eur J Immunol 1992;22:2825-2830.
8. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989;169:493-502.
9. Sykes M, Szot GL, Swenson KA, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997;3:783-787.
10. Huang CA, Yamada K, Murphy MC, Shimizu A, Colvin RB, Neville DM Jr, et al. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9. Transplantation 1999;68:855-860.
11. Fuchimoto Y, Huang CA, Yamada K, Shimizu A, Kitamura H, Colvin RB, et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 2000;105:1779-1789.
12. Kawai T, Poncelet A, Sachs DH, Mauiyyedi S, Boskovic S, Wee SL, et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 1999;68:1767-1775.
13. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999;68: 480-484.
14. Rubin JP, Cober SR, Butler PE, Randolph MA, Gazelle GS, Ierino FL, et al. Injection of allogeneic bone marrow cells into the portal vein of swine in utero. J Surg Res 2001;95:188-194.
15. Mathes DW, Yamada K, Randolph MA, Utsugi R, Solari MG, Gazelle GS, et al. In utero induction of transplantation tolerance. Transplant Proc 2001;33:98-100.
16. Foster RD, Fan L, Neipp M, Kaufman C, McCalmont T, Ascher N, et al. Donor-specific tolerance induction in composite tissue allografts [corrected; erratum to be published]. Am J Surg 1998;176:418-421.
17. Hettiaratchy SP, Melendy E, Randolph MA, Huang CA, Sachs DH, Lee WP, et al. Tolerance to limb allografts in a large animal model. Presented at the 47th Plastic Surgery Research Council, Boston, MA, April 18-20, 2002.
18. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381:434-438.
19. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999;5:686-693.
20. Lee WP, Rubin JP, Bourget JL, Cober SR, Randolph MA, Nielson GP, et al. Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens. Plast Reconstr Surg 2001;107:1482-1491.
21. Mathes DW, Bourget JL, Randolph MA, Solari WG, Wu A, Sachs DH, et al. Tolerance to vascularized musculoskeletal allografts. Transplant Proc 2001;33:616-617.
22. Katz SM, Hong JC, Kahan BD. New immunosuppressive agents. Transplant Proc 2000;32:620-621.
23. Kahan BD. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction. Transplantation 2001;71:S52-S57.
24. Williams JW, Mital D, Chong A, Kottayil A, Millis M, Longstreth J, et al. Experiences with leflunomide in solid organ transplantation. Transplantation 2002;73:358-366.
25. Kahan BD. FTY720: a new immunosuppressive agent with novel mechanism(s) of action. Transplant Proc 1998;30: 2210-2213.
26. Thomas JM, Eckhoff DE, Contreras JL, Lobashevsky AL, Hubbard WJ, Moore JK, et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 2000; 69:2497-2503.
27. Calne R, Moffatt SD, Friend PJ, Jamieson NV, Bradley JA, Hale G, et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999;68:1613-1616.
28. Morelon E, Kreis H. New immunosuppressive agents: a way to get rid of corticosteroids? Transplantation 2000;70:1271-1272.
29. Francois CG, Breidenbach WC, Maldonado C, Kakoulidis TP, Hodges A, Dubernard JM, et al. Hand transplantation: comparisons and observations of the first four clinical cases. Microsurgery 2000;20:360-371.
30. Fujita T, Takahashi S, Yagihashi A, Jimbow K, Sato N, Prolonged survival of rat skin allograft by treatment with FK506 ointment. Transplantation 1997;64:922-925.
31. Yuzawa K, Taniguchi H, Seino K, Otsuka M, Fukao K. Topical immunosuppression in skin grafting with FK 506 ointment. Transplant Proc 1996;28:1387-1389.
32. Panhans-Groß A, Novak N, Kraft S, Bieber T. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol 2001;107:345-352.
33. Wollenberg A, Sharma S, Von Bubnoff D, Geiger E, Haberstock J, Bieber T. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2001;107:519-525.
34. Granstein RD, Smith L, Parrish JA. Prolongation of murine skin allograft survival by the systemic effects of 8-methoxypsoralen and long-wave ultraviolet radiation (PUVA). J Invest Dermatol 1987;88:424-429.
35. Deeg HJ. Ultraviolet irradiation in transplantation biology. Manipulation of immunity and immunogenicity. Transplantation 1988;45:845-851.
36. Lee WP, Mathes DW. Hand transplantation: pertinent data and future outlook. J Hand Surg 1999;24A:906-913.
37. Hettiaratchy S, Butler PE, Lee WP. Lessons from hand transplantations. Lancet 2001;357:494-495.
38. Lee WP. Composite tissue transplantation: more science and patience needed. Plast Reconstr Surg 2001;107:1066-1070.